These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1899903

  • 1. The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.
    Molero X, Miller LJ.
    Mol Pharmacol; 1991 Feb; 39(2):150-6. PubMed ID: 1899903
    [Abstract] [Full Text] [Related]

  • 2. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP.
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [Abstract] [Full Text] [Related]

  • 3. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
    [Abstract] [Full Text] [Related]

  • 4. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM, Ji Z, Pinon DI, Henne RM, Lybrand TP, Miller LJ.
    J Med Chem; 1999 Jun 17; 42(12):2105-11. PubMed ID: 10377216
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 17; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
    Clin Cancer Res; 1999 Oct 17; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL, Fouraux MA, Pouwels W, van Emst-de Vries SE, Ronken E, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Jul 27; 124(5):935-45. PubMed ID: 9692779
    [Abstract] [Full Text] [Related]

  • 12. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
    Klueppelberg UG, Molero X, Barrett RW, Miller LJ.
    Mol Pharmacol; 1990 Aug 27; 38(2):159-63. PubMed ID: 2200953
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M, Behr TM.
    Biopolymers; 2002 Aug 27; 66(6):399-418. PubMed ID: 12658727
    [Abstract] [Full Text] [Related]

  • 15. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A, Ong H, Gutkowska J, Schiller PW, McNicoll N.
    Mol Pharmacol; 1984 Nov 27; 26(3):498-508. PubMed ID: 6092899
    [Abstract] [Full Text] [Related]

  • 16. Characterization of CCK(A) receptor affinity states and Ca(2+) signal transduction in vagal nodose ganglia.
    Lankisch TO, Tsunoda Y, Lu Y, Owyang C.
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun 27; 282(6):G1002-8. PubMed ID: 12016125
    [Abstract] [Full Text] [Related]

  • 17. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W, Povoski SP, Bell RH.
    J Surg Res; 1995 Mar 27; 58(3):281-9. PubMed ID: 7533864
    [Abstract] [Full Text] [Related]

  • 18. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov 27; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

  • 19. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 27; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas.
    Le Meuth V, Philouze-Rome V, Le Huerou-Luron I, Formal M, Vaysse N, Gespach C, Guilloteau P, Fourmy D.
    Endocrinology; 1993 Sep 27; 133(3):1182-91. PubMed ID: 8365360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.